124339-32-8

Basic information

• Product Name: tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name)
• Synonyms: tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name)
• CAS NO: 124339-32-8
• Molecular Formula: C₄₂H₆₅N₅O₇
• Molecular Weight: 751.9948
• Mol File: 124339-32-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 993.2°C at 760 mmHg
• Flash Point: 554.5°C
• Density: 1.14g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.552
• CAS DataBase Reference: tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name)(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name)(124339-32-8)
• EPA Substance Registry System: tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name)(124339-32-8)

Safety Data

• Hazardous Substances Data: 124339-32-8(Hazardous Substances Data)

Usage

General Description

The chemical tert-butyl [(2S,3S)-6-{[(2S,3S)-5-{[(2S)-1-{[3-(aminomethyl)benzyl]amino}-4-methyl-1-oxopentan-2-yl]amino}-1-cyclohexyl-3-hydroxy-5-oxopentan-2-yl]amino}-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate (non-preferred name) is a complex compound with a bulky tertiary butyl group attached to a carbamate group. It contains multiple amino acid residues, including benzylamine, cyclohexylamine, and phenylalanine, as well as hydroxy and oxo functional groups. The structure suggests that it may have potential biological activity or pharmaceutical application, given the presence of multiple functional groups that can interact with biological targets. However, the specific properties and uses of this compound would need to be further investigated and elucidated.

Upstream product

• 82001-64-7 (E)-(S)-<1-(phenylmethyl)-5-(trimethylsilyl)-3-hexen-5-ynyl>carbamic acid 1,1-dimethylethyl ester 
• 82042-48-6 (S)-5-<(tert-Butoxycarbonyl)amino>-6-phenyl-(E)-3-hexenoic acid 
• 118457-05-9 Methyl (S)-5-<(tert-butoxycarbonyl)amino>-6-phenyl-(E)-3-hexenoate 
• 118405-01-9 Boc-PheΨACHPA-Leu-NHCH2-m-Ph-CH2NHZ 
• 124266-92-8 [3-((S)-1-tert-Butoxycarbonylamino-2-phenyl-ethyl)-oxiranyl]-acetic acid methyl ester 
• 99113-32-3 (2E,4R,S,5S)-5-<<(1,1-dimethylethoxy)carbonyl>amino>-4-hydroxy-6-phenyl-2-hexenoic acid 

Relevant articles and documents

Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites

Renin inhibitors having 13 different isosteres connecting the P3 and P2 positions have been prepared. Synthetic routes and in vitro activity exhibited by these compounds are discussed. The two most potent compounds, 47 and 48, contai